The medicines regulator has upheld a complaint that an article naming UK sources of weight loss drug supply breached advertising regulations banning the promotion of POMs to the public.

Some 25 complaints have been submitted to the Competition and Markets Authority (CMA) arguing that the new pharmacy contract is “anti-competitive”, C+D has learned. Kate Bowie joined C+D as a digital ...

Pfizer has announced it will “discontinue” the development of a weight loss pill amid “potential drug-induced liver injury”, less than two years after it decided “not [to] advance” a previous version.